celecoxib has been researched along with Age-Related Osteoporosis in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, clinical data suggest that chronic use of celecoxib, may impair normal skeletal function leading to decreased bone mineral density in older male patients." | 2.44 | Celecoxib, NSAIDs and the skeleton. ( Lysz, T; O'Connor, JP, 2008) |
| "The treatment with celecoxib or vehicle was started immediately after the sham operation or ovariectomy, and lasted for 4 weeks." | 1.34 | The selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivo. ( Baylink, DJ; Itoi, E; Kasukawa, Y; Maekawa, S; Miyakoshi, N; Mohan, S; Nozaka, K; Srivastava, AK, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Cui, Y | 1 |
| Chen, Y | 1 |
| Gao, X | 1 |
| Su, Y | 1 |
| Cui, L | 1 |
| Barozzi, N | 1 |
| Peeters, GM | 1 |
| Tett, SE | 1 |
| O'Connor, JP | 1 |
| Lysz, T | 1 |
| Pfeifer, M | 1 |
| Kasukawa, Y | 1 |
| Miyakoshi, N | 1 |
| Srivastava, AK | 1 |
| Nozaka, K | 1 |
| Maekawa, S | 1 |
| Baylink, DJ | 1 |
| Mohan, S | 1 |
| Itoi, E | 1 |
| Hachulla, E | 1 |
1 review available for celecoxib and Age-Related Osteoporosis
| Article | Year |
|---|---|
Celecoxib, NSAIDs and the skeleton.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Bone and Bones; Bone Regeneration; Cele | 2008 |
5 other studies available for celecoxib and Age-Related Osteoporosis
| Article | Year |
|---|---|
Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats.
Topics: Animals; Antirheumatic Agents; Biomarkers; Body Weight; Bone and Bones; Bone Density; Bone Resorptio | 2015 |
Actions following adverse drug events - how do these influence uptake and utilisation of newer and/or similar medications?
Topics: Aged; Australia; Bone Density Conservation Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Diphospho | 2015 |
[Analgesic in osteoporosis. Why so conservative with dosage?].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Diclofenac; Dos | 2002 |
The selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivo.
Topics: Analysis of Variance; Animals; Bone Density; Bone Resorption; Celecoxib; Collagen Type I; Cyclooxyge | 2007 |
[64th Congress of the American College of Rheumatology, Philadelphia, October 28-November 2, 2000].
Topics: Amyloidosis; Antiphospholipid Syndrome; Behcet Syndrome; Celecoxib; Cyclooxygenase Inhibitors; Giant | 2001 |